Sensato Investors

Sensato Investors was a San Francisco-based investment management firm and SEC-registered investment adviser focused on Asia-Pacific equity long-short strategies. The firm used a systematic, research-driven investment process rather than developing therapeutics, medical products, or healthcare services. Public business-directory and fund-profile sources describe Sensato Investors as having been founded in 2009 and operating as a hedge fund or alternative asset manager. SEC adviser records indicate its SEC registration was terminated on September 18, 2020, so it does not appear to be an active operating life sciences company.